Fraser Wares

Recent Contributions

Reply to [ARCHIVED] Anti-TB Drugs and Arrhythmia: Theoretical Concern or Real Risk?

July 10, 2015
The need of monitoring of QTc is obviously not limited to patients on bedaquiline, but also to patients at potentially higher risk of cardiotoxicity. That is the case of some countries implementing shorter regimens for the treatment of MDR-TB, which include two QTc prolonging drugs (moxifloxacin and clofazimine). Findings from ...

Reply to Call for application for membership to the Core Group of Global Drug-resistant TB Initiative (GDI)

Dec. 21, 2013
Dear Dr Adagba, Many thanks for your interest in being part of the GDI. As stated in the my last email , please visit: http://stoptb.org/wg/ and click on the link 'Global Drug-resistant TB Initiative' for information related to the GDI. The link to join the GDI is on the last ...

Reply to Call for application for membership to the Core Group of Global Drug-resistant TB Initiative (GDI)

Dec. 20, 2013
Dear Dr Ige, Many thanks for your interest in applying to be considered as a member of the GDI Core Group. We are happy to inform you that the Global Drug-resistant TB Initiative (GDI) website is now live. Please visit: http://stoptb.org/wg/ and click on the link 'Global Drug-resistant TB Initiative' ...

Reply to [ARCHIVED] Lessons Learned in India: E-Compliance for TB Treatment by Operation ASHA

July 10, 2013
Firstly I would like to congratulate Dr Batra, Abhishek and Operation AHSA on the innovative project to match the advances in information technology with the challenge of supporting TB patients through to successful completion of treatment in India. The challenge of creating effective patient centred care for TB patients in ...


Recent Recommendations

None at this time.